Xeris Biopharma Holdings (XERS) Earnings Date & Reports

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

XERS is expected to report earnings to rise 53.33% to -4 cents per share on May 07

Xeris Biopharma Holdings XERS Stock Earnings Reports

Q1'25

Est.

$-0.05

Q4'24

Beat

by $0.03

Q3'24

Missed

by $0.02

Q2'24

Est.

$-0.10

Q1'24

Missed

by $0.04

The last earnings report on March 06 showed earnings per share of -2 cents, beating the estimate of -5 cents. With 2.96M shares outstanding, the current market capitalization sits at 792.79M.

View a ticker or compare two or three

Compare

XERS